George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@JHFH not seen him on Twitter before but basically is posting about all the shares I'm either in or watching - let's hope that's a good omen not a bad one :'-D
https://twitter.com/WarrenBuffegg
That fellow, seems to have lots of followers, idk how big an influence he has, but he is someone different, usually only me and like 3-4 others ever post on twitter about hemo, I have like 10 followers or something so my influence is tiny :P
THE warren?!
Naw I am not here to ramp, I prefer smaller rises if I am honest, I think its about to get thumbs up by warren on twitter which will massively expose Hemo to his what 30k? followers. So you will probably get your wish, not be surprised to see a bit of a swarm of small investments this afternoon. I just hope they do their homework and realise the full potential not just the next RNS that comes along.
@JHFH....come on buddy, you can get this to 6.5p
Still think it is Bayer and surprise news will hit us by next Friday.
I'm exhausted reading it.
The only thing more reliable than someone on Twitter giving an investment opportunity is if it written on the wall above a urinal in a dodgy pub. With the pubs closed at the moment I realise that we all have to rely on Twitter but come tomorrow the real expert advice will be back again.
Just thought I'd lighten the mood!
Let's move on Guys...Think we have exhausted this discussion.....!
GLA!
Someone on twitter? And you believed them over your own research/conclusions?
Yorkshireone, less of a coincidence when you consider that there is obviously a market and if a big company got wind that their competitor was working on something and they thought they had a chance to get there first they might go for it. But it's still close.
OnTarget, no sorry it was not Hemo themselves who said this to me, someone on twitter, blocked me then apparently posted I was wrong stating they had got it direct from the horses mouth. I personally have not had any communication from Hemogenyx or anyone linked to them on this matter
It's also a bit odd that HEMO (assuming that's who told him) would confirm it's not a particular company, rather than no comment.
Is it possible they are just trying to throw you of the scent JHFH to stop this getting out any further?
IMO....There is good reason to think Pfizer are a possible candidate...as JHFH has
highlighted. We wil not know until the big reveal in the next few weeks...But
I am confident that it will be a major player and we wil not be disappointed!
As another poster mentioned, it is the detail of the deal that really matters..
as that is what adds the value here....Vlad and Co know the worth of what
HEMO bring to the table, and major pharmas typically make their money
identifying the smaller pharmas that are working on life-changing pipelines/
life saving..in our case. The commercial potential of these small pharmas is
massive, so they are prepared to make a significant investment in the early
stages as if they call it right it will make them Billions....So hopefully
our deal will be significant....and the market will recognise we have
moved into a new phase...
GLA!
Hopefully a Covid update will land shortly too.......
no worries, anyway I have to drop off here, catch you all later
Sorry ignore my last question - too early in the morning!
RE:" Another question - how are you linking that paper to Pfizer?"
There is a wee + symbol near the top click it to expand ;-)
Affiliations
1Cancer Immunology Discovery, Oncology R&D, Pfizer Inc., South San Francisco, CA 94080, USA. Electronic address: yeungyik**********.
2Cancer Immunology Discovery, Oncology R&D, Pfizer Inc., South San Francisco, CA 94080, USA.
3Biomedicine Design, Pfizer Inc., San Diego, CA 94080, USA.
4Drug Safety R&D, Pfizer Inc., San Diego, CA 94080, USA.
5Cancer Immunology Discovery, Oncology R&D, Pfizer Inc., South San Francisco, CA 94080, USA. Electronic address: javier.chaparro-riggers@pfizer.com.
6Cancer Immunology Discovery, Oncology R&D, Pfizer Inc., South San Francisco, CA 94080, USA. Electronic address: ivanadj@hotmail.com.
RE: "Is it possible GlobalCo are working in partnership with Pfizer, but HEMO's agreement is with Globalco rather than Pfizer?"
Never really considered that as a possibility but yes I would guess that is certainly possible and much preferable to NOT being our CDX candidate. Interesting possibility though!
Another question - how are you linking that paper to Pfizer?
RE the Car-T announcement
"As previously announced, Hemogenyx’s CDX product has the potential to treat Acute Myeloid Leukemia (AML) directly as well as providing a benign conditioning regimen for blood stem cell replacement therapy. The Company has now carried out extensive work developing treatments for AML and has to date obtained encouraging results."
The date is 15 Jan 2020
https://pubmed.ncbi.nlm.nih.gov/31981494/ - the date is 2020 Jan 14 one day before and it contains:
"We demonstrated that 7370 has picomolar potency against AML cell lines in vitro and in vivo. 7370 was also capable of activating T cells from AML patients"
Is it possible GlobalCo are working in partnership with Pfizer, but HEMO's agreement is with Globalco rather than Pfizer?
Also what has HEMO's CAR-T announcement got to do with someone else's CDX paper?
Yes Ontarget, thats the point it looks very similar, and I stated previously if its NOT the same product then Pfizer are working on their own candidate and are ready for human trials with successful pre-clinical results. By all accounts they would be ahead of or tied neck and neck with the Hemo candidate but with billions behind them targeting EXACTLY the same problem that Hemo is addressing.
Either it IS Hemos candidate OR its not, and honestly if its not then our project would be in serious difficulties, its huge potential because its first in the field and unique with no competition.
The negative consequences if its nothing to do with Hemogenyx is MASSIVE, I just dont think thats possible, just too many concidences
And when I say something similar maybe I should say 'looks similar to the layperson'.
You're assuming because the paper describes something similar to HEMO's CDX product that it must be HEMO's CDX product. Probably this assumption is false.